• 1. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

Introduction to Ethyl 5-Acetamido-3-Methylthiophene-2-Carboxylate (CAS No. 353461-19-5)

Ethyl 5-acetamido-3-methylthiophene-2-carboxylate (CAS No. 353461-19-5) is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include an acetamido group, a methylthiophene moiety, and an ester functional group. These structural elements contribute to its potential biological activities and make it a valuable candidate for various applications in drug discovery and development.

The chemical structure of ethyl 5-acetamido-3-methylthiophene-2-carboxylate can be represented as C₁₁H₁₃NO₃S. The presence of the thiophene ring, which is a five-membered heterocyclic compound containing one sulfur atom, imparts unique electronic and steric properties to the molecule. The acetamido group, on the other hand, is known for its ability to form hydrogen bonds, which can enhance the compound's interactions with biological targets. The ester group further adds to the molecule's versatility by influencing its solubility and metabolic stability.

In recent years, ethyl 5-acetamido-3-methylthiophene-2-carboxylate has been the subject of extensive research due to its potential therapeutic applications. One of the key areas of interest is its anti-inflammatory properties. Studies have shown that this compound can effectively inhibit the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These findings suggest that ethyl 5-acetamido-3-methylthiophene-2-carboxylate could be a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory effects, ethyl 5-acetamido-3-methylthiophene-2-carboxylate has also been investigated for its potential as an antitumor agent. Research has demonstrated that this compound can induce apoptosis in various cancer cell lines, including those derived from breast cancer and colon cancer. The mechanism of action appears to involve the modulation of key signaling pathways such as the mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. These findings highlight the potential of ethyl 5-acetamido-3-methylthiophene-2-carboxylate as a lead compound for the development of novel anticancer drugs.

The pharmacokinetic properties of ethyl 5-acetamido-3-methylthiophene-2-carboxylate have also been studied in detail. Preclinical studies have shown that this compound exhibits good oral bioavailability and favorable pharmacokinetic parameters, making it suitable for further development as an orally administered drug. Additionally, its metabolic stability has been evaluated using both in vitro and in vivo models, with results indicating that it undergoes minimal metabolism by cytochrome P450 enzymes, which is a desirable property for drug candidates.

In terms of safety, preliminary toxicological studies have suggested that ethyl 5-acetamido-3-methylthiophene-2-carboxylate has a low toxicity profile at therapeutic doses. However, further investigations are needed to fully characterize its safety profile and to identify any potential side effects or contraindications. These studies are crucial for ensuring that the compound can be safely translated from preclinical research to clinical trials.

The synthesis of ethyl 5-acetamido-3-methylthiophene-2-carboxylate has been optimized using various synthetic routes, with a focus on improving yield and purity while minimizing environmental impact. One common approach involves the condensation of ethyl thiophene carboxylate with acetamide in the presence of a suitable catalyst. This method has been shown to produce high yields of the desired product with excellent purity levels, making it suitable for large-scale production.

In conclusion, ethyl 5-acetamido-3-methylthiophene-2-carboxylate (CAS No. 353461-19-5) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further research and development in the fields of medicinal chemistry and pharmaceutical sciences. As ongoing studies continue to uncover new insights into its mechanisms of action and safety profile, it is likely that this compound will play an increasingly important role in the discovery and development of novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)